Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 2 boards, counting each seat separately. Longest: BioMarin Pharmaceutical Inc., 2 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
BioMarin Pharmaceutical Inc. June 2, 202698.2%
-
Charles River Laboratories International Inc. May 5, 202698.8%
-
BioMarin Pharmaceutical Inc. May 20, 202599.2%
-
BioMarin Pharmaceutical Inc. May 21, 202499.6%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 2, 2026 | BioMarin Pharmaceutical Inc. | Grant or award | +7,490 | — | — |
| May 8, 2026 | Charles River Laboratories International Inc. | Grant or award | +1,438 | $177.62 | $255,418 |
| Jun 2, 2025 | Charles River Laboratories International Inc. | Grant or award | +946 | $135.04 | $127,748 |
| May 20, 2025 | BioMarin Pharmaceutical Inc. | Grant or award | +6,650 | — | — |
| May 21, 2024 | BioMarin Pharmaceutical Inc. | Grant or award | +4,720 | — | — |
| Dec 27, 2023 | BioMarin Pharmaceutical Inc. | Grant or award | +2,180 | — | — |
Questions about Mark J. Enyedy
What boards is Mark J. Enyedy on?
Mark J. Enyedy sits on the boards of BioMarin Pharmaceutical Inc. and Charles River Laboratories International Inc.
How long has Mark J. Enyedy served on boards?
Our records show at least 4 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.